Drug Type Small molecule drug |
Synonyms Trospectinomycin, U 63366 F, U-63,366 + [1] |
Target |
Action inhibitors |
Mechanism 30S subunit inhibitors(30S ribosomal subunit inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhaseDiscontinuedNDA/BLA |
First Approval Date- |
Regulation- |
Molecular FormulaC17H30N2O7 |
InChIKeyKHAUBYTYGDOYRU-IRXASZMISA-N |
CAS Registry88669-04-9 |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Bacterial Infections | NDA/BLA | Belgium | - | - |
| Bacterial Infections | NDA/BLA | Germany | - | - |
| Bacterial Infections | NDA/BLA | Greece | - | - |
| Bacterial Infections | NDA/BLA | Mexico | - | - |
| Bacterial Infections | NDA/BLA | Netherlands | - | - |
| Bacterial Infections | NDA/BLA | Portugal | - | - |
| Bacterial Infections | NDA/BLA | Spain | - | - |
| Gonorrhea | Phase 2 | United States | - | |
| Reproductive Tract Infections | Phase 2 | United States | - | |
| Respiratory Tract Infections | Phase 2 | United States | - |





